loadpatents
Patent applications and USPTO patent grants for Sellmer; Andreas.The latest application filed is for "synthesis, pharmacology and use of new and selective fms-like tyrosine kinase 3 (flt3) flt3 inhibitors".
Patent | Date |
---|---|
Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors Grant 11,384,076 - Mahboobi , et al. July 12, 2 | 2022-07-12 |
Synthesis, Pharmacology And Use Of New And Selective Fms-like Tyrosine Kinase 3 (flt3) Flt3 Inhibitors App 20200190075 - MAHBOOBI; SIAVOSH ;   et al. | 2020-06-18 |
HDAC6 inhibitors and their uses Grant 10,106,540 - Mahboobi , et al. October 23, 2 | 2018-10-23 |
Novel Hdac6 Inhibitors And Their Uses App 20170210743 - MAHBOOBI; Siavosh ;   et al. | 2017-07-27 |
Novel Bifunctional Compounds Which Inhibit Protein Kinases And Histone Deacetylases App 20110065734 - Bar; Thomas ;   et al. | 2011-03-17 |
Novel lapacho compounds and methods of use thereof App 20060142271 - Muller; Klaus ;   et al. | 2006-06-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.